Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2009

Conditions
Pancreatic Cancer
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

RADIATION

radiation therapy

Trial Locations (17)

60590

Arbeitsgruppe Lebermetastasen und Tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie, Frankfurt

A-6020

Innsbruck Universitaetsklinik, Innsbruck

A-1090

Allgemeines Krankenhaus - Universitatskliniken, Vienna

D-13125

Robert Roessle Comprehensive Cancer Center - Charite Campus Buch, Berlin

D-44892

Knappschaft Krankenhaus, Bochum

D-28239

DIAKO Ev. Diakonie Krankenhaus gGmbH, Bremen

D-01008

Krankenhaus Dresden - Friedrichstadt, Dresden

D-91054

Universitaet Erlangen, Erlangen

D-73035

Klinik am Eichert, Göppingen

D-69120

Chirurgische Universitaetsklinik, Heidelberg

D-04103

Universitaet Leipzig, Leipzig

D-39130

Staedtisches Klinikum Magdeburg, Magdeburg

D-81377

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich

D-90419

Klinikum Nuernberg - Klinikum Nord, Nuremberg

D-93053

Klinikum der Universitaet Regensburg, Regensburg

D-72076

Universitaetsklinikum Tuebingen, Tübingen

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft

OTHER

NCT00335543 - Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | Biotech Hunter | Biotech Hunter